# OnCo record john-leonard (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/john-leonard/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "john-leonard" ;
  schema:name "John P. Leonard"@en ;
  schema:description "New York lymphoma specialist who led AUGMENT, the trial that established lenalidomide plus rituximab as a chemotherapy-free option for relapsed follicular and marginal zone lymphoma."@en ;
  schema:url <https://onco.cc/people/john-leonard/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "lymphoma", "trialist" ;
  schema:jobTitle "Haematologist-oncologist, Weill Cornell Medicine" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:institutions <https://onco.cc/institutions/weill-cornell-meyer-cancer-center/> ;
  onco:trials <https://onco.cc/trials/augment/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-augment-lenalidomide-rituximab-leonard-jco-2019/> ;
  schema:affiliation <https://onco.cc/institutions/weill-cornell-meyer-cancer-center/> .